102 related articles for article (PubMed ID: 2633145)
1. [Concentration of carcinoembryonic antigen in the serum and bronchoalveolar lavage fluid in patients with lung cancer].
Płusa T; Bejm J; Józefczak E; Swierz J; Drzewiecki Z
Pneumonol Pol; 1989 May; 57(5):277-82. PubMed ID: 2633145
[TBL] [Abstract][Full Text] [Related]
2. [Value of determining the concentration of carcinoembryonic antigen in bronchial lavage for diagnosis of lung cancer].
Załeska J; Pirozyński M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1995; 63(5-6):286-92. PubMed ID: 7581059
[TBL] [Abstract][Full Text] [Related]
3. CEA, NSE and SCC Ag in bronchial lavage in patients with lung cancer.
Załeska J; Pirozynski M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():179-89. PubMed ID: 9337536
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoembryonic antigen (CEA) in the blood serum of patients with bronchogenic carcinoma and selected diseases of the respiratory tract].
Szklarz E; Gawlikowski W
Pneumonol Pol; 1989 Apr; 57(4):217-21. PubMed ID: 2628950
[TBL] [Abstract][Full Text] [Related]
5. [Carcinoembryonic antigen in bronchoalveolar lavage fluids in the diagnosis of lung cancer].
Molodyk AA; Krumm AV
Med Radiol (Mosk); 1986 Nov; 31(11):51-5. PubMed ID: 3784828
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
[TBL] [Abstract][Full Text] [Related]
7. [CEA distribution in BALF of lung cancer patients].
Xu WB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):371-3. PubMed ID: 2855411
[No Abstract] [Full Text] [Related]
8. [Diagnostic significance of carcinoembryonic antigen measurement in bronchial lavage fluids in bronchial carcinoma].
Ma WL
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):349-50, 380-1. PubMed ID: 1964877
[TBL] [Abstract][Full Text] [Related]
9. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
[TBL] [Abstract][Full Text] [Related]
13. [Alpha fetoprotein levels in the serum and bronchoalveolar lavage fluid in patients with lung cancer and other diseases of the respiratory system].
Płusa T; Bejm J; Józefczak E; Piechota W; Mamełka B
Pneumonol Alergol Pol; 1992; 60(1-2):15-9. PubMed ID: 1283967
[TBL] [Abstract][Full Text] [Related]
14. [Carcinoembryonic antigen assay in serum and pleural effusion of pulmonary malignancies and benign lesions].
Jiang XF; Zhu YJ; Zhao WL; Ma X; Lo WC
Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):430-1. PubMed ID: 3582109
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of carcinoembryonic antigen determination in bronchoalveolar lavage fluid. A comparative study among patients with peripheral lung cancer, pneumonia, and healthy individuals.
de Diego A; Compte L; Sanchis J; Enguidanos MJ; Marco V
Chest; 1991 Oct; 100(4):1060-3. PubMed ID: 1914558
[TBL] [Abstract][Full Text] [Related]
16. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
18. [Carcinoembryonic antigen (CEA) in the bronchoalveolar lavage fluid from patients with lung cancer (author's transl)].
Shiraki R; Kinoshita M; Wagai F; Watanabe H; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Apr; 20(4):398-402. PubMed ID: 7109365
[No Abstract] [Full Text] [Related]
19. Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay.
Pompecki R; Shively JE; Todd CW
Cancer Res; 1981 May; 41(5):1910-5. PubMed ID: 6163531
[TBL] [Abstract][Full Text] [Related]
20. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
